Evotec SE (1EVT)
MTA
Real-time Data
07:00 AM
Day's Range
3.3552 wk Range
3.28Overview - 1EVT - Evotec SE
Key Statistics
Valuation
Enterprise Value
605.13M
P/E (Trailing)
‪-5.77‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪0.83‬
Price / Book
‪0.89‬
EV / EBITDA
‪-8.26‬
Profitability
Gross Margin
‪-1.00%‬
Profit Margin
‪-27.47%‬
Operating Margin
‪-62.25%‬
Return on Assets
‪-5.39%‬
Return on Equity
‪-26.07%‬
Ownership
Shares Outstanding
177.59M
Float
135.38M
Held by Insiders
‪9.96%‬
Held by Institutions
‪61.24%‬
Price stats
Beta
‪1.26‬
50-Day Avg
‪4.10‬
200-Day Avg
‪5.03‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1EVT - Evotec SE
Peers - 1EVT - Evotec SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1EVTMTAEvotec SE1.13BMarket Cap-84.02%52-week change-5.83P/E (Trailing)‪-27.47%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+20.17%52-week change23.47P/E (Trailing)‪11.21%‬Profit Margin
- 1ZTSMTAZoetis Inc.48.46BMarket Cap-106.01%52-week change12.02P/E (Trailing)‪27.68%‬Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+22.58%52-week change55.38P/E (Trailing)‪14.57%‬Profit Margin
- 1NBIXMTANeurocrine Biosciences Inc.12.55BMarket Cap+19.30%52-week change22.23P/E (Trailing)‪20.91%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+36.15%52-week change-4.70P/E (Trailing)‪-2.78%‬Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+38.32%52-week change118.86P/E (Trailing)‪4.51%‬Profit Margin
Profile Summary - 1EVT - Evotec SE
About
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrated drug discovery solutions on a fee-for-service basis or via…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
